653O Glecirasib (KRAS G12C inhibitor) in combination with JAB-3312 (SHP2 inhibitor) in patients with KRAS p.G12C mutated solid tumors

Authors:
  • JWJ. Wang
    J. Wang
  • JZJ. Zhao
    J. Zhao
  • JZJ. Zhong
    J. Zhong
  • XLX. Li
    X. Li
  • JFJ. Fang
    J. Fang
  • YYY. Yu
    Y. Yu
  • XFX. Fang
    X. Fang
  • JCJ. Chang
    J. Chang
  • ZLZ. Liu
    Z. Liu
  • YZY. Zhao
    Y. Zhao
  • QSQ. Song
    Q. Song
  • CBC. Bai
    C. Bai

Abstract
No abstract available